UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012237 |
|---|---|
| Receipt number | R000014309 |
| Scientific Title | Additional biomarker study of Randomized Phase III Study of Pemetrexed + Cisplatin and Vinorelbine + Cisplatin for Completely Resected Non-squamous Non-Small Cell Lung Cancer |
| Date of disclosure of the study information | 2013/11/08 |
| Last modified on | 2022/01/18 15:03:41 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/11/07 19:56:17 | ||
| 2 | Update | 2014/07/01 17:58:00 | Recruitment status |
|
| 3 | Update | 2014/07/01 18:01:15 | Organization Organization Category of Funding Organization Name of secondary funder(s) Name of secondary funder(s) |
|
| 4 | Update | 2016/05/14 15:00:23 | Name of primary person or sponsor Organization |
|
| 5 | Update | 2016/06/07 20:08:15 | Organization1 Email1 |
|
| 6 | Update | 2018/01/09 12:38:32 | Recruitment status |
|
| 7 | Update | 2021/11/02 13:44:42 | Recruitment status Date of IRB Last follow-up date |
|
| 8 | Update | 2021/11/02 14:35:50 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 9 | Update | 2022/01/18 15:03:41 | Recruitment status |
